These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21414849)

  • 1. Costimulatory signals potently modulate the T cell inhibitory capacity of the therapeutic CD11a antibody Efalizumab.
    Kuschei WM; Leitner J; Majdic O; Pickl WF; Zlabinger GJ; Grabmeier-Pfistershammer K; Steinberger P
    Clin Immunol; 2011 May; 139(2):199-207. PubMed ID: 21414849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness.
    Guttman-Yassky E; Vugmeyster Y; Lowes MA; Chamian F; Kikuchi T; Kagen M; Gilleaudeau P; Lee E; Hunte B; Howell K; Dummer W; Bodary SC; Krueger JG
    J Invest Dermatol; 2008 May; 128(5):1182-91. PubMed ID: 18239614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efalizumab modulates T cell function both in vivo and in vitro.
    Koszik F; Stary G; Selenko-Gebauer N; Stingl G
    J Dermatol Sci; 2010 Dec; 60(3):159-66. PubMed ID: 21044829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T Cells.
    Leitner J; Herndler-Brandstetter D; Zlabinger GJ; Grubeck-Loebenstein B; Steinberger P
    J Immunol; 2015 Jul; 195(2):477-87. PubMed ID: 26041540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topo-proteomic in situ analysis of psoriatic plaque under efalizumab treatment.
    Bonnekoh B; Pommer AJ; Böckelmann R; Hofmeister H; Philipsen L; Gollnick H
    Skin Pharmacol Physiol; 2007; 20(5):237-52. PubMed ID: 17587888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
    Bartik MM; Bauman GP; Brooks WH; Roszman TL
    Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
    Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
    Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
    Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
    Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.
    Witsch EJ; Peiser M; Hutloff A; Büchner K; Dorner BG; Jonuleit H; Mages HW; Kroczek RA
    Eur J Immunol; 2002 Sep; 32(9):2680-6. PubMed ID: 12207353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosslinking of CD27 in the presence of CD28 costimulation results in T cell proliferation and cytokine production.
    Sunder-Plassmann R; Pickl WF; Majdic O; Knapp W; Holter W
    Cell Immunol; 1995 Aug; 164(1):20-7. PubMed ID: 7634349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD2 regulates responsiveness of activated T cells to interleukin 12.
    Gollob JA; Li J; Reinherz EL; Ritz J
    J Exp Med; 1995 Sep; 182(3):721-31. PubMed ID: 7544396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
    Watson CL; Furlong SJ; Hoskin DW
    Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of cloned human T lymphocytes via the CD3 or CD28 molecules induces enhancement in vascular endothelial permeability to macromolecules with participation of type-1 and type-2 intercellular adhesion pathways.
    Damle NK; Doyle LV
    Eur J Immunol; 1990 Sep; 20(9):1995-2003. PubMed ID: 1698638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of costimulatory molecule 4-1BB and CD28 in activating of various T cell subsets from human peripheral blood].
    Wu JY; Qian F; Lu HZ; Wang W; Li BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):533-6. PubMed ID: 15367340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level IL-10 production by monoclonal antibody-stimulated human T cells.
    Schwarz M; Majdic O; Knapp W; Holter W
    Immunology; 1995 Nov; 86(3):364-71. PubMed ID: 8550072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.